Upgrade to SI Premium - Free Trial

BTIG Reiterates Buy Rating on Adicet Bio Inc. (ACET)

August 14, 2024 6:11 AM
BTIG analyst Justin Zelin reiterated a Buy rating and $6.00 price target on Adicet Bio Inc. (NASDAQ: ACET).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles